Menopause & Depression: Is Your Low Mood Hormonal?

The Feeling That Has No Name

Many women in their 40s and 50s describe something that is hard to put into words.

Not grief. Not anxiety. Not the picture of depression they had imagined, someone unable to get out of bed. Just a flatness. A quietness where enthusiasm used to live. Things that once mattered feel distant and colourless. Getting through the day feels heavier than it should. Their family looks at them and sees nothing obviously wrong. And they wonder: is this menopause, or is something actually wrong with me?

It is often both. And once you understand what is driving it, this kind of depression responds well to treatment.

This post focuses specifically on clinical depression during menopause, not on the broader range of mood changes that perimenopause brings. If you are experiencing anxiety, irritability, or mood swings, the Menopause & Anxiety guide covers those symptoms in depth. Depression is a distinct condition with its own biology, diagnostic criteria, and treatment pathway. That is what we will explore here.

What the Research Shows

The Study of Women’s Health Across the Nation (SWAN) is one of the largest long-term studies on women’s health ever conducted. Its findings on depression are significant: women in the menopausal transition had substantially higher rates of major depressive episodes compared to pre-menopausal women of the same age, including women with no prior history of depression.

Two points from this research matter most for clinical practice:

First: Perimenopause (the transition, when hormones fluctuate most erratically) carries a higher depression risk than post-menopause (when oestrogen has settled at a stable low). It is the unpredictability of oestrogen, not simply its lower level, that appears most disruptive to mood. Many women expect to feel better “once it is all over.” For mood, the most difficult window is often the transition itself, not the destination.

For more on this, read our guide on Perimenopause Mood Changes. Second: The risk exists even for women who have never been depressed before. Perimenopause is not simply a trigger for pre-existing vulnerability. It can cause first-episode depression in women with no psychiatric history. This is a neurobiological event, not a character flaw.

Research published in the Archives of General Psychiatry (Freeman et al.) found that the odds of developing clinically significant depressive symptoms were 2 to 4 times higher during the perimenopausal transition than in the pre-menopausal phase, after controlling for other variables including life stressors and sleep.

The Biology: How Oestrogen Drives Depression

Two overlapping pathways connect declining oestrogen to clinical depression.

The Serotonin Pathway

Oestrogen has a direct relationship with the serotonin system. It promotes serotonin synthesis, increases the density of serotonin receptors in the prefrontal cortex and limbic system (the brain’s mood-regulating regions), and modulates the serotonin transporter protein that clears serotonin from synapses.

When oestrogen fluctuates and declines, serotonin activity is disrupted. SSRIs (selective serotonin reuptake inhibitors), the most commonly prescribed antidepressants, work precisely on this system. The fact that these medications are effective for menopausal depression is consistent with the biology: oestrogen decline creates a serotonin deficit that antidepressants can partially correct.

The HPA Axis

The hypothalamic-pituitary-adrenal axis governs the body’s stress response. Oestrogen has a calming effect on HPA axis reactivity. During perimenopause, as oestrogen fluctuates, the HPA axis becomes dysregulated, leading to higher basal cortisol levels and an exaggerated response to even minor stressors.

The result: situations that were manageable before now feel overwhelming. This is not weakness or life circumstances changing. It is a measurable shift in stress-response biology. The same day-to-day pressures that you handled competently for decades are now arriving in a brain whose stress-dampening system is less effective.

Sleep Disruption as a Compounding Factor

Menopause-related insomnia is not just an accompanying symptom of depression. It is a direct contributor. Chronic sleep disruption impairs the brain’s emotional regulation circuits independently of hormones. Night sweats that fragment sleep night after night create a cumulative sleep debt that mimics and worsens depressive symptoms. Treating insomnia is not optional when depression is present.

Depression or Low Mood? How to Tell the Difference

Low mood and clinical depression are not the same condition, and the distinction matters for treatment.

Low mood fluctuates. Good days interrupt difficult ones. It responds to lifestyle changes: a walk, a good night’s sleep, time with friends.

Clinical depression is more persistent and more impairing. The clinical criteria (DSM-5) require that five or more of the following symptoms have been present on most days for at least two weeks, and that they represent a change from previous functioning:

• Depressed mood most of the day (feeling sad, empty, or hopeless)
• Markedly diminished interest or pleasure in all or almost all activities
• Significant weight loss or gain without trying
• Insomnia or sleeping too much
• Feeling physically slowed down or restless in a way that others notice
• Fatigue or loss of energy nearly every day
• Feelings of worthlessness, or excessive or inappropriate guilt
• Difficulty thinking, concentrating, or making decisions
• Recurrent thoughts of death or self-harm

At least one of the five symptoms must be either depressed mood or loss of interest and pleasure.

Using the PHQ-9

The PHQ-9 is a validated nine-question screening tool for depression. It is widely used in clinical practice and freely available. Rate each of the following on a scale of 0 (not at all) to 3 (nearly every day) for how often you have been bothered over the past two weeks:

1. Little interest or pleasure in doing things
2. Feeling down, depressed, or hopeless
3. Trouble falling or staying asleep, or sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself, or feeling like a failure, or that you have let yourself or your family down
7. Trouble concentrating on things
8. Moving or speaking so slowly that others notice, or being so restless you are moving around more than usual
9. Thoughts that you would be better off dead, or thoughts of hurting yourself in some way

Scoring: 1 to 4 = minimal; 5 to 9 = mild depression; 10 to 14 = moderate depression; 15 to 19 = moderately severe; 20 and above = severe depression.

A score of 1 or more on question 9 warrants immediate support, regardless of the total score.

The PHQ-9 does not replace a clinical assessment. But it gives you a concrete number to take to your doctor, rather than trying to describe feelings in a five-minute appointment.

A note on overlap with menopause symptoms: Fatigue, sleep disruption, and difficulty concentrating are common to both perimenopause and depression. When assessing yourself, ask: are these symptoms disproportionate to the menopause context? Fatigue that does not lift even after a reasonable night’s sleep, and low mood that does not ease on good days, points toward clinical depression rather than menopause symptoms alone.

For more on this, read our guide on Menopause Fatigue.

Who Is at Higher Risk?

Not every woman in perimenopause will develop clinical depression. Certain factors increase the risk substantially.

Prior history of depression, postnatal depression, or severe PMS. The brain’s mood circuitry has demonstrated sensitivity to hormonal change in these women. The same oestrogen-serotonin sensitivity that made previous transitions difficult makes the menopausal transition harder. This is not destiny, but it is a reason to be proactive rather than reactive.

Surgical menopause. Women who enter menopause suddenly after removal of both ovaries face a rapid oestrogen drop rather than a gradual transition. The brain has less time to adapt. Rates of depression following surgical menopause are higher than in natural menopause.

Chronic sleep disruption. Women whose sleep has been fragmented by night sweats for months accumulate a sleep debt that independently elevates depression risk. Sleep is not a soft lifestyle factor here. It is a physiological variable with direct effects on brain chemistry.

High allostatic load. Many Indian women in their 40s are managing multiple simultaneous burdens: aging parents who need care, children in critical academic phases, marriage and household responsibilities, and often a career as well. This “sandwich generation” stress does not cause hormonal depression, but it reduces resilience at exactly the time when hormonal changes are making the brain more vulnerable. Neither the hormones nor the stress alone tells the whole story.

Unaddressed brain fog. Cognitive difficulties during perimenopause, such as poor concentration, difficulty remembering words, and mental slowness, are distressing. When women do not understand that these are hormonal and temporary, they construct a narrative: “something is wrong with me,” “I am losing my mind,” “I cannot do my job anymore.” This narrative becomes a direct pathway to depressive thinking. Naming brain fog accurately is a protective act.

Low social support. Isolation amplifies the impact of mood disturbance at a neurobiological level. Indian women who cannot speak openly about what they are experiencing, whether because of cultural expectation, family dynamics, or simple lack of vocabulary for perimenopause, are at higher risk of untreated depression.

Evidence-Based Treatment for Menopausal Depression

The right treatment depends on severity, prior history, and individual circumstances. Here is what has evidence behind it.

Exercise: Accessible, Effective, and Underutilised

The evidence for exercise as a treatment for mild to moderate depression is extensive. For perimenopausal women specifically, it does more than lift mood: it improves sleep quality, reduces cortisol, reduces hot flashes, and provides a sense of agency during a time when many women feel that their body is changing without their permission.

Target 30 minutes of moderate aerobic activity on most days. Walking, swimming, and cycling all count. Resistance training two to three times per week adds further benefit through its effects on cortisol regulation and physical confidence. The minimum effective dose is meaningful: even 20 minutes of brisk walking five days a week produces measurable mood benefits.

Cognitive Behavioural Therapy (CBT)

Multiple randomised controlled trials confirm that CBT is effective for menopause-related depression and anxiety. A trained therapist helps you identify thought patterns that sustain low mood, develop practical coping strategies, and address sleep disruption directly (CBT-I, the cognitive behavioural therapy protocol specifically for insomnia, is more effective than sleep medication for long-term outcomes).

CBT is appropriate as a standalone first-line treatment for mild to moderate depression, and it works well alongside medication or HRT when symptoms are more severe. In India, access to trained CBT therapists has expanded significantly through online platforms.

Oestrogen Therapy for Perimenopausal Depression

For women whose depression is clearly linked to the hormonal fluctuations of perimenopause, oestrogen therapy has demonstrated clinical effectiveness. A 2001 randomised controlled trial by Soares and colleagues (Archives of General Psychiatry) found that transdermal oestradiol was significantly more effective than placebo for treating depression in perimenopausal women, including women with no prior psychiatric history.

This is an important clinical distinction: oestrogen therapy for mood works best during perimenopause, when hormonal fluctuation is the primary driver. It is less effective for established clinical depression unrelated to the hormonal transition, and for post-menopausal women where oestrogen has already stabilised at its new lower level. This is why an assessment that takes hormonal status seriously is worth more than a generic prescription.

Antidepressants

For moderate to severe depression, and for women who cannot take HRT or prefer not to, SSRIs (fluoxetine, sertraline, escitalopram) or SNRIs (venlafaxine, duloxetine) are appropriate and effective. These medications directly address the serotonin deficit that oestrogen decline creates.

There is no shame in needing medication. Depression is a medical condition with measurable neurochemical changes. SSRIs prescribed for depression do not blunt personality, create dependence, or represent failure. For many women, a time-limited course of antidepressants during the perimenopausal transition is what allows them to re-engage with their lives while other lifestyle changes take hold.

Venlafaxine and paroxetine have the additional benefit of reducing hot flashes independent of their antidepressant effects, which is useful when both symptoms are present and HRT is not appropriate.

Omega-3 Fatty Acids as an Adjunct

Meta-analyses of omega-3 supplementation for depression have found a modest but consistent benefit, particularly for EPA-dominant formulations at 1 to 2 grams per day. The mechanism appears to involve anti-inflammatory effects on brain function. Indian dietary sources include ground flaxseed, walnuts, and fatty fish. Supplementation is reasonable as an adjunct to other treatment, not as a standalone intervention for clinical depression.

Nutrition and Gut Health

Mood and diet are connected through the gut-brain axis. The gut produces a large proportion of the body’s serotonin (though this peripheral serotonin does not cross the blood-brain barrier directly; gut health influences mood through the vagus nerve and systemic inflammatory pathways). Gut microbiome diversity correlates with mood. A diet built around whole grains (ragi, bajra, jowar), fermented foods (dahi, idli, kanji), diverse vegetables, and dals provides the substrate for a healthy gut-brain connection. Reducing ultra-processed foods and added sugar reduces the blood glucose spikes that worsen mood instability. These changes are supportive, not curative for clinical depression, but they form the foundation everything else builds on.

When to See a Psychiatrist

Your gynaecologist or general practitioner can diagnose and manage mild to moderate depression. A psychiatrist is the right specialist when:

• Your PHQ-9 score is 10 or above
• You are experiencing any thoughts of self-harm or death, however fleeting or passive
• Symptoms have not improved meaningfully after six to eight weeks of lifestyle changes
• You have a personal or family history of bipolar disorder (perimenopause can trigger mood episodes in bipolar women and requires specialist management)
• You are experiencing psychotic features (rare, but possible)
• You are on antidepressants and your mood is not stabilising

A psychiatrist and a gynaecologist working together give you the most complete picture. The hormonal context matters for medication choices, and a psychiatrist who understands perimenopause will factor oestrogen status into the assessment.

If you are in Coimbatore, Dr. Varsha Viswanathan (Psychiatrist and Psychotherapist) is part of the Menolia clinical team and works alongside Dr. Suganya for women who need both hormonal and psychiatric support.

Depression and the Indian Context

In Indian families, there is rarely language for what perimenopausal depression actually is. Women are expected to keep the household running, remain emotionally available for everyone else, and not “make a fuss.” Depression is framed as weakness, ingratitude, or a spiritual problem. “So many women go through worse. Just be strong.”

This means that many women arrive at their 40s and 50s never having told anyone, including their doctor, what is actually happening emotionally. They describe physical symptoms because those feel more acceptable: tiredness, headaches, aches in the joints. The inner truth stays hidden.

The compounding effect is that untreated depression in perimenopause does not simply resolve on its own for most women. It shapes how the entire transition is experienced. It affects relationships, work, and how women enter the post-menopausal years.

Naming what you are experiencing, clearly and without apology, is a clinical act. It is not dramatic. It is medically precise.

If you are reading this and recognising yourself, you do not need to earn the right to feel better. You do not need to be in crisis. And you do not need to have the right words when you reach out. Starting the conversation is enough.

---

Frequently Asked Questions

How do I know if my low mood is hormonal or clinical depression?

Both can be true at the same time. Hormonal changes can drive clinical depression. The question to ask is whether the symptoms meet the clinical threshold: most days, for at least two weeks, significantly affecting your functioning. Use the PHQ-9 as a starting point (score 5 and above suggests mild depression, 10 and above moderate). If your low mood began around the time your periods became irregular and you also have other menopause symptoms, the hormonal link is likely. Discuss the timing with your doctor. Hormonal depression responds to oestrogen therapy in a way that unrelated depression does not.

Is menopause depression different from depression at other life stages?

There are similarities but important differences. Perimenopausal depression is directly triggered by oestrogen fluctuation disrupting the serotonin system. It can occur in women with no prior psychiatric history. It responds to oestrogen therapy in ways that other forms of depression do not. And it co-occurs with other menopause symptoms (sleep disruption, brain fog, hot flashes) that need simultaneous attention. This does not make it “less real” or less serious than depression at other life stages. It means the assessment and treatment approach need to account for the hormonal context.

Can HRT treat menopausal depression?

For women whose depression is clearly linked to the hormonal fluctuations of perimenopause, yes. A randomised controlled trial by Soares et al. (Archives of General Psychiatry, 2001) found that transdermal oestradiol was significantly more effective than placebo for perimenopausal depression. The effect was meaningful and was seen in women with no prior psychiatric history. HRT is not a replacement for antidepressants in established clinical depression that is unrelated to hormonal changes. A proper assessment determines which approach fits.

Will the depression go away once menopause is complete?

For some women, depressive symptoms ease when hormones stabilise in post-menopause. But untreated depression during the transition can become entrenched, particularly when it is accompanied by sleep disruption, social withdrawal, and inactivity. Waiting passively is rarely the fastest path through. Early intervention, even modest lifestyle changes alongside a conversation with your doctor, significantly improves outcomes.

What Indian foods help with mood during menopause?

Focus on nutrients that support the serotonin system. Tryptophan (serotonin precursor) is found in dahi, paneer, dal, and eggs. Omega-3 fatty acids (anti-inflammatory, supports brain function) come from ground flaxseed, walnuts, and fatty fish. Vitamin D is linked to depression risk when deficient, and deficiency is common in Indian women due to indoor lifestyles. Magnesium (calming, supports sleep quality) is found in bajra, pumpkin seeds, and dark leafy greens. Build meals around ragi, dal, dahi, and vegetables as a foundation. No single food cures depression, but a nourishing whole-food diet reduces the biological burden and supports every other intervention.

Should I see a psychiatrist or a gynaecologist for menopausal depression?

Both are relevant. Your gynaecologist or OB-GYN can assess the hormonal context, consider HRT, and manage mild to moderate depression. A psychiatrist is the right specialist if your PHQ-9 score is 10 or above, if you are having any thoughts of self-harm, if you have a history of bipolar disorder, or if symptoms do not improve with initial treatment. At Menolia, Dr. Suganya works alongside Dr. Varsha Viswanathan (Psychiatrist and Psychotherapist) for women who need coordinated care across both dimensions.

I have never been depressed before. Could this really be depression?

Yes. The research is clear that perimenopause can cause first-episode depression in women with no prior psychiatric history. This is a neurobiological event driven by oestrogen’s direct effects on the brain’s serotonin and stress-response systems. The absence of a prior history is not a reason to dismiss symptoms. If anything, first-episode depression in perimenopause is a strong indicator that hormonal treatment deserves serious consideration alongside other approaches.